Research and Development

Access to sophisticated rapid blood tests for malaria has improved dramatically in recent years but there are still issues in …

Transparency is one of those words for which the exact meaning has become clouded by murkier connotations. The chances are …

Merck KGaA’s share price is 7% down over the course of the year – a year that, on the pharmaceutical …

Why immunotherapies are successful in some individuals and not in others is a matter of huge importance to both patients …

As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …

GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …

Just over two weeks ago, Tissue Regenix announced that its long-standing CEO, Antony Odell, would be leaving the company. It …

The FDA has issued a warning over cannabis-based therapies which promise the ability to cure cancer, asserting that such treatments …

Scientists in the US have reported findings suggesting that certain molecules in the blood are strongly associated with complications during …

Only yesterday it was revealed that Novartis had applied to the FDA in the same indication that Gilead’s treatment is …

Topas Therapeutics, a German company focused on developing novel therapeutics to treat immune-mediated and autoimmune diseases, announced that it has …

Matt Fellows investigates how the first-ever CAR-T therapy approvals in the past months could mean the field of cancer treatment …

In a rare spot of good news for Tecentriq (atezolizumab), after a turbulent period, Roche’s drug has been given the …

Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges …

A group of states, 45 members-strong, has expanded its probe into the generics pharmaceutical industry by expanding its case to …